Krill oil and reacted astaxanthin composition and associated method

Abstract

A method of enhancing cardiovascular health includes administering a therapeutic amount of a composition comprising krill oil reacted with astaxanthin. A medicine delivery system for the method and composition includes an inner capsule containing carotenoids and an outer capsule in which the inner capsule is contained within the outer capsule and the outer capsule containing a therapeutically effective amount of krill oil. In one example, the carotenoids comprise at least S, S′-astaxanthin derived from Haematococcus pluvialis.

That which is claimed is: 
     
         1 . A method of enhancing cardiovascular health comprises administering a therapeutic amount of a composition comprising krill oil reacted with astaxanthin. 
     
     
         2 . The method according to  claim 1 , wherein the astaxanthin comprises S,S′-astaxanthin derived from  Haematococcus pluvialis.    
     
     
         3 . The method according to  claim 1 , wherein the krill oil comprises phospholipid bound and triglyceride bound EPA and DHA, the krill oil comprising 30% total phospholipids. 
     
     
         4 . The method according to  claim 1 , further comprising administering 50 to 1000 mg of krill oil. 
     
     
         5 . The method according to  claim 1 , further comprising administering one or more of lutein and/or trans-zeaxanthin or meso-zeaxanthin. 
     
     
         6 . The method according to  claim 5 , further comprising administering 0.5 to B mg of astaxanthin, 2 to 15 mg of lutein and 0.2 to 12 mg of trans-zeaxanthin. 
     
     
         7 . The method according to  claim 1 , further comprising administering the composition as a dietary supplement composition. 
     
     
         8 . The method according to  claim 1 , further comprising administering the composition as a food product. 
     
     
         9 . The method according to  claim 1 , further comprising administering the composition as a cosmetic applied to the skin. 
     
     
         10 . The method according to  claim 1 , further comprising reacting the krill oil and astaxanthin after ingesting an outer capsule containing the krill oil and an inner capsule containing the astaxanthin. 
     
     
         11 . A composition to enhance cardiovascular health comprising a therapeutic amount of krill oil reacted with astaxanthin. 
     
     
         12 . The composition according to  claim 11 , wherein the astaxanthin comprises S,S′-astaxanthin derived from  Haematococcus pluvialis.    
     
     
         13 . The composition according to  claim 11 , wherein the krill oil comprises phospholipid bound and triglyceride bound EPA and DHA, the krill oil comprising 30% total phospholipids. 
     
     
         14 . The composition according to  claim 11 , further comprising 50 to 1000 mg of krill oil per dosage. 
     
     
         15 . The composition according to  claim 11 , further comprising one or more of lutein and/or trans-zeaxanthin or meso-zeaxanthin. 
     
     
         16 . The composition according to  claim 11 , further comprising 0.5 to 8 mg of astaxanthin, 2 to 15 mg of lutein and 0.2 to 12 mg of trans-zeaxanthin. 
     
     
         17 . The composition according to  claim 11 , wherein the composition comprises a dietary supplement composition. 
     
     
         18 . The composition according to  claim 11 , wherein the composition comprises a food product. 
     
     
         19 . The composition according to  claim 11 , wherein the composition comprises a cosmetic.